Status:
COMPLETED
Expression of Angiogenic Factors in Myocardial Tissue
Lead Sponsor:
University of Virginia
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate whether angiogenesis is decreased in diabetic patients with coronary artery disease compared to non-diabetics with coronary artery disease. The protein express...
Detailed Description
Coronary artery disease and its complications are the leading cause of death in the western world. Diabetes mellitus (DM) is one of the major risk factors to develop coronary artery disease, myocardia...
Eligibility Criteria
Inclusion
- on-pump CABG
- 18 years of age \& older
- informed consent
Exclusion
- active malignancy
- severe lung disease (requiring home O2 therapy)
- severe anemia\<8g/dl
- patient with moderate or severe renal dysfunction
- off- pump CABG
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01414621
Start Date
August 1 2009
End Date
August 1 2011
Last Update
March 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia Health System
Charlottesville, Virginia, United States, 22908